We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.31%
This Fund
S&P 500
This Quarter Est. Return
+0.22%
1 Year Est. Return
+106.31%
3 Year Est. Return
+266.76%
5 Year Est. Return
+310.53%
10 Year Est. Return
+1,580.35%
AUM
$4.22B
AUM Growth
-$970M
Cap. Flow
-$969M
Cap. Flow %
-22.94%
Top 10 Hldgs %
17.21%
Holding
1,976
New
447
Increased
357
Reduced
374
Closed
503

Sector Composition

Rank Sector Weight
1 Healthcare 14.12%
2 Technology 11.17%
3 Industrials 6.47%
4 Consumer Discretionary 6.13%
5 Financials 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLACR
1351
DELISTED
Global Lights Acquisition Corp Rights
GLACR
$41.2K ﹤0.01%
196,397
MIST icon
1352
Milestone Pharmaceuticals
MIST
$138M
$40.6K ﹤0.01%
30,779
CMTL icon
1353
Comtech Telecommunications
CMTL
$50.3M
$40.4K ﹤0.01%
13,327
-3,722
-22% -$8.82K
TBMCR
1354
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$40K ﹤0.01%
336,600
RFACR
1355
DELISTED
RF Acquisition Corp. Rights
RFACR
$39.8K ﹤0.01%
400,000
PSNY icon
1356
Polestar Automotive Holding UK
PSNY
$2.09B
$39.5K ﹤0.01%
+1,675
New +$56K
NCNCW
1357
DELISTED
noco-noco Inc. Warrant
NCNCW
$39.4K ﹤0.01%
222,749
BKHAR
1358
Black Hawk Acquisition Corp Rights
BKHAR
$38.9K ﹤0.01%
+35,375
New +$40.9K
IGTAR
1359
DELISTED
Inception Growth Acquisition Limited Rights
IGTAR
$38.8K ﹤0.01%
250,000
CLRCR
1360
DELISTED
ClimateRock Right
CLRCR
$38.4K ﹤0.01%
300,000
BLACR
1361
DELISTED
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
$37.5K ﹤0.01%
311,040
MARXR
1362
DELISTED
Mars Acquisition Corp. Rights
MARXR
$37K ﹤0.01%
168,396
IBACR
1363
IB Acquisition Corp Right
IBACR
$35K ﹤0.01%
+462,793
New +$42.4K
CHRS icon
1364
Coherus Oncology
CHRS
$217M
$35K ﹤0.01%
20,218
-1,046
-5% -$2.1K
ABLVW icon
1365
Able View Global Warrant
ABLVW
$136K
$34.4K ﹤0.01%
37,000
ALSAR
1366
DELISTED
Alpha Star Acquisition Corp Rights
ALSAR
$34.4K ﹤0.01%
360,200
CDIOW icon
1367
Cardio Diagnostics Holdings Inc Warrant
CDIOW
$730K
$33.3K ﹤0.01%
60,540
ASCBR
1368
DELISTED
A SPAC II Acquisition Corp. Right
ASCBR
$31.5K ﹤0.01%
450,000
OPEN icon
1369
Opendoor
OPEN
$3.64B
$28.8K ﹤0.01%
+16,153
New +$34.8K
DRMAW icon
1370
Dermata Therapeutics Warrant
DRMAW
$14.1K
$28.7K ﹤0.01%
12,000
AREBW
1371
DELISTED
American Rebel Holdings Warrants
AREBW
$28.3K ﹤0.01%
602
GODNR
1372
DELISTED
Golden Star Acquisition Corporation Rights
GODNR
$26.4K ﹤0.01%
72,600
SIFY
1373
Sify Technologies
SIFY
$1.06B
$26.2K ﹤0.01%
+9,913
New +$63.1K
BUJAR
1374
DELISTED
Bukit Jalil Global Acquisition 1 Ltd. Rights
BUJAR
$26K ﹤0.01%
173,250
TUYA
1375
Tuya Inc
TUYA
$1.03B
$25.6K ﹤0.01%
+15,000
New +$27.3K

Similar funds

Boothbay Fund Management's Q2 2024 Portfolio in Review

As of Q2 2024, Boothbay Fund Management held 1,976 positions worth $4.22B, down 19% from $5.19B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management withdrew a net $969M in Q2 2024, closing 503 positions and reducing 374 holdings. Its most notable exit was Exact Sciences, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Boothbay Fund Management opened a new position in Sprott Physical Gold and Silver Trust worth $21.5M.

  • Boothbay Fund Management's largest Q2 2024 buy was Sprott Physical Gold and Silver Trust: 976,153 shares worth $21.5M.
  • Boothbay Fund Management added most to Apple in Q2 2024, an estimated $19.6M increase.
  • Boothbay Fund Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $62.1M.
  • Boothbay Fund Management fully exited Exact Sciences in Q2 2024, selling an estimated $22.8M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.22B portfolio in Q2 2024.
  • Boothbay Fund Management opened 447 new positions and closed 503 in Q2 2024.
  • Boothbay Fund Management's portfolio value fell 19% quarter-over-quarter to $4.22B.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.